<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="https://pharmatlas.org/lib/exe/css.php?s=feed" type="text/css"?>
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="https://pharmatlas.org/feed.php">
        <title> - cardio:ccb</title>
        <description></description>
        <link>https://pharmatlas.org/</link>
        <image rdf:resource="https://pharmatlas.org/lib/exe/fetch.php?media=logo.png" />
       <dc:date>2026-04-06T07:37:03+00:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="https://pharmatlas.org/doku.php?id=cardio:ccb:amlodipine&amp;rev=1770945222&amp;do=diff"/>
                <rdf:li rdf:resource="https://pharmatlas.org/doku.php?id=cardio:ccb:clevidipine&amp;rev=1770945529&amp;do=diff"/>
                <rdf:li rdf:resource="https://pharmatlas.org/doku.php?id=cardio:ccb:dhp&amp;rev=1770945368&amp;do=diff"/>
                <rdf:li rdf:resource="https://pharmatlas.org/doku.php?id=cardio:ccb:diltiazem&amp;rev=1770945291&amp;do=diff"/>
                <rdf:li rdf:resource="https://pharmatlas.org/doku.php?id=cardio:ccb:felodipine&amp;rev=1770945453&amp;do=diff"/>
                <rdf:li rdf:resource="https://pharmatlas.org/doku.php?id=cardio:ccb:nicardipine&amp;rev=1770945492&amp;do=diff"/>
                <rdf:li rdf:resource="https://pharmatlas.org/doku.php?id=cardio:ccb:nifedipine&amp;rev=1770945421&amp;do=diff"/>
                <rdf:li rdf:resource="https://pharmatlas.org/doku.php?id=cardio:ccb:non_dhp&amp;rev=1770938632&amp;do=diff"/>
                <rdf:li rdf:resource="https://pharmatlas.org/doku.php?id=cardio:ccb:start&amp;rev=1770945190&amp;do=diff"/>
                <rdf:li rdf:resource="https://pharmatlas.org/doku.php?id=cardio:ccb:verapamil&amp;rev=1770945254&amp;do=diff"/>
            </rdf:Seq>
        </items>
    </channel>
    <image rdf:about="https://pharmatlas.org/lib/exe/fetch.php?media=logo.png">
        <title></title>
        <link>https://pharmatlas.org/</link>
        <url>https://pharmatlas.org/lib/exe/fetch.php?media=logo.png</url>
    </image>
    <item rdf:about="https://pharmatlas.org/doku.php?id=cardio:ccb:amlodipine&amp;rev=1770945222&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-13T01:13:42+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>amlodipine</title>
        <link>https://pharmatlas.org/doku.php?id=cardio:ccb:amlodipine&amp;rev=1770945222&amp;do=diff</link>
        <description>Amlodipine

Amlodipine is a long-acting Dihydropyridine Calcium Channel Blocker (DHP CCB).

It primarily causes arterial vasodilation and reduces systemic vascular resistance.

Used in:

	*  Hypertension
	*  Stable Angina
	*  Vasospastic angina

→ Calcium Channel Blockers

----------

Mechanism of Action

Amlodipine blocks L-type calcium channels in vascular smooth muscle.</description>
    </item>
    <item rdf:about="https://pharmatlas.org/doku.php?id=cardio:ccb:clevidipine&amp;rev=1770945529&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-13T01:18:49+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>clevidipine</title>
        <link>https://pharmatlas.org/doku.php?id=cardio:ccb:clevidipine&amp;rev=1770945529&amp;do=diff</link>
        <description>Clevidipine

Clevidipine is an ultra–short-acting Dihydropyridine Calcium Channel Blocker (DHP CCB).

It is a potent, rapidly titratable intravenous arterial vasodilator used in hypertensive emergencies.

Used in:

	*  Hypertensive emergency
	*  Perioperative blood pressure control
	*  Neurocritical care BP management</description>
    </item>
    <item rdf:about="https://pharmatlas.org/doku.php?id=cardio:ccb:dhp&amp;rev=1770945368&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-13T01:16:08+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>dhp</title>
        <link>https://pharmatlas.org/doku.php?id=cardio:ccb:dhp&amp;rev=1770945368&amp;do=diff</link>
        <description>Dihydropyridine Calcium Channel Blockers

Dihydropyridine Calcium Channel Blockers (DHP CCBs) are potent arterial vasodilators that reduce systemic vascular resistance (SVR) by blocking L-type calcium channels in vascular smooth muscle.

They are primarily used for:</description>
    </item>
    <item rdf:about="https://pharmatlas.org/doku.php?id=cardio:ccb:diltiazem&amp;rev=1770945291&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-13T01:14:51+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>diltiazem</title>
        <link>https://pharmatlas.org/doku.php?id=cardio:ccb:diltiazem&amp;rev=1770945291&amp;do=diff</link>
        <description>Diltiazem

Diltiazem is a Non-Dihydropyridine Calcium Channel Blocker (Non-DHP CCB).

It has both cardiac and vascular effects and is commonly used for rate control and angina.

Used in:

	*  Dysrhythmias
	*  Stable Angina
	*  Hypertension

→ Calcium Channel Blockers

----------

Mechanism of Action

Diltiazem blocks L-type calcium channels in:

	*  SA node</description>
    </item>
    <item rdf:about="https://pharmatlas.org/doku.php?id=cardio:ccb:felodipine&amp;rev=1770945453&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-13T01:17:33+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>felodipine</title>
        <link>https://pharmatlas.org/doku.php?id=cardio:ccb:felodipine&amp;rev=1770945453&amp;do=diff</link>
        <description>Felodipine

Felodipine is a Dihydropyridine Calcium Channel Blocker (DHP CCB).

It primarily causes arterial vasodilation and reduces systemic vascular resistance.

Used in:

	*  Hypertension
	*  Stable Angina

→ Calcium Channel Blockers

----------

Mechanism of Action

Felodipine blocks L-type calcium channels in vascular smooth muscle.</description>
    </item>
    <item rdf:about="https://pharmatlas.org/doku.php?id=cardio:ccb:nicardipine&amp;rev=1770945492&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-13T01:18:12+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>nicardipine</title>
        <link>https://pharmatlas.org/doku.php?id=cardio:ccb:nicardipine&amp;rev=1770945492&amp;do=diff</link>
        <description>Nicardipine

Nicardipine is a Dihydropyridine Calcium Channel Blocker (DHP CCB).

It is a potent arterial vasodilator available in both oral and intravenous formulations.

Used in:

	*  Hypertension
	*  Hypertensive emergency (IV)
	*  Angina

→ Calcium Channel Blockers

----------

Mechanism of Action

Nicardipine blocks L-type calcium channels in vascular smooth muscle.</description>
    </item>
    <item rdf:about="https://pharmatlas.org/doku.php?id=cardio:ccb:nifedipine&amp;rev=1770945421&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-13T01:17:01+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>nifedipine</title>
        <link>https://pharmatlas.org/doku.php?id=cardio:ccb:nifedipine&amp;rev=1770945421&amp;do=diff</link>
        <description>Nifedipine

Nifedipine is a Dihydropyridine Calcium Channel Blocker (DHP CCB).

It primarily causes arterial vasodilation and reduces systemic vascular resistance.

Used in:

	*  Hypertension
	*  Stable Angina
	*  Vasospastic angina
	*  Raynaud phenomenon

→ Calcium Channel Blockers

----------

Mechanism of Action

Nifedipine blocks L-type calcium channels in vascular smooth muscle.</description>
    </item>
    <item rdf:about="https://pharmatlas.org/doku.php?id=cardio:ccb:non_dhp&amp;rev=1770938632&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-12T23:23:52+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>non_dhp</title>
        <link>https://pharmatlas.org/doku.php?id=cardio:ccb:non_dhp&amp;rev=1770938632&amp;do=diff</link>
        <description>Non-Dihydropyridine Calcium Channel Blockers

Non-Dihydropyridine Calcium Channel Blockers (Non-DHP CCBs) block L-type calcium channels in both cardiac myocytes and vascular smooth muscle.

Unlike Dihydropyridine Calcium Channel Blockers, Non-DHP agents significantly affect cardiac conduction and contractility.</description>
    </item>
    <item rdf:about="https://pharmatlas.org/doku.php?id=cardio:ccb:start&amp;rev=1770945190&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-13T01:13:10+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>start</title>
        <link>https://pharmatlas.org/doku.php?id=cardio:ccb:start&amp;rev=1770945190&amp;do=diff</link>
        <description>Calcium Channel Blockers (CCBs)

Calcium Channel Blockers inhibit L-type calcium channels in cardiac and vascular smooth muscle.

They reduce intracellular calcium, leading to:

	*  ↓ Contractility
	*  ↓ Heart rate (some agents)
	*  ↓ Afterload</description>
    </item>
    <item rdf:about="https://pharmatlas.org/doku.php?id=cardio:ccb:verapamil&amp;rev=1770945254&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-02-13T01:14:14+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>verapamil</title>
        <link>https://pharmatlas.org/doku.php?id=cardio:ccb:verapamil&amp;rev=1770945254&amp;do=diff</link>
        <description>Verapamil

Verapamil is a Non-Dihydropyridine Calcium Channel Blocker (Non-DHP CCB).

It primarily affects cardiac tissue and AV nodal conduction.

Used in:

	*  Dysrhythmias (rate control)
	*  Stable Angina
	*  Hypertension

→ Calcium Channel Blockers

----------

Mechanism of Action

Verapamil blocks L-type calcium channels in:

	*  SA node
	*  AV node</description>
    </item>
</rdf:RDF>
